Orion Market Research (OMR) recently published a
market research report on Global Genome
Editing Market. According to OMR
analysis, the global genome editing market is expected to grow significantly
during the forecast period (2018-2023) coupled with increasing funding for
genome editing research. Additionally, the global genome editing market is
segmented on the basis of technologies, application, end-users and regional
outlook. The report provides detailed & insightful chapters which include
market overview, key findings, strategic recommendations, market estimations,
market determinants, key company analysis, market insights, company profiling,
market segmentation, geographical analysis, patent analysis, analyst insights
and predictive analysis of the market.
Increasing
funding for genome editing research is primarily contributing towards the
market growth. National Institute of Health (NIH) has declared a plan in Jan
2018 to fund $190 million for research in genome editing. It is an effort
intended for removing restrictions that reduces the use of genome editing for
the treatment of patients. This new program named Somatic Cell Genome Editing
by NIH will grant funding to the biomedical researchers in the six years from
the beginning of 2018. These biomedical researchers will work together to
improve the delivery mechanisms that enables to target gene editing tools among
patients and develop new and advanced genome editors. In addition, they will
develop assays to test the safety and effectiveness of the genome editing tools
in human and animal cells as well as assemble a genome editing toolkit that
will contain subsequent tools, methods and knowledge to be shared with the
scientific community.
Full report of global genome editing market is
available at https://www.omrglobal.com/industry-reports/genome-editing-market/
Moreover, in
June 2018, Precision Biosciences, Inc. (a US-based biotechnology firm) closed
an oversubscribed series B funding of $110 million. This funding is aimed for
efforts on product development which is based on its platform, ARCUS genome
editing. The funding was led by Arrow Mark Partners and other new investors
such as Franklin Templeton Investments, Cowen Healthcare Investments and Adage
Capital Management. This is intended to broaden the applications of its genome
editing platform, ARCUS in the areas of genetic disease and immuno-oncology,
which in turn is expected to lead the way for the company to set up as a wholly
integrated biotechnology firm. they will use this funding to leverage and expanding
its product portfolio. Such kinds of funding activities are showing increasing
focus on genome editing techniques, which in turn will lead to propel the
market growth.
About Orion Market Research
Orion Market
Research (OMR) is an Indian research company known for its crisp and
concise reports. The company is equipped with an experienced team and young
brigade of analysts. The company provides quality syndicated research reports,
customized research reports, company profiling, consulting and other
research-based services. OMR provide global and regional market reports of
various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR
provide a 360-degree view of the market with parametric analysis, key market
insights, key findings, statistical forecasts, competitive landscape, extensive
segmentation, key trends, strategic recommendations and detailed company
profiles.
Comprehensive research
methodology of global Genome editing market:
·
In-depth analysis of
macro and micro factors influencing the market guided by key recommendations.
·
Analysis of regional
regulations and other government policies impacting the global genome editing
market.
·
Insights about market
determinants which are stimulating the global genome editing market.
·
Detailed and extensive
market segments with regional distribution of forecasted revenues.
·
Extensive profiles and
recent developments of market players.
Media
Contact:
Company
Name: Orion Market Reports
Contact
Person: Mr. Anurag Tiwari
Email:
info@omrglobal.com
Contact
no: +1 646-755-7667, +91 780-304-0404
No comments:
Post a Comment